Camp4 Therapeutics Corporation

Healthcare · Biotechnology · United States

Last price 3.9 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 244.74M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015...